CTOs on the Move

Aprecia

www.aprecia.com

 
Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® Technology to transform the way people take medicine. Its first innovation, ZipDose Technology can be combined with a wide variety of active pharmaceutical ingredients to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address unmet treatment needs to eliminate patient suffering and caregiver burden.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.aprecia.com
  • 10901 Kenwood Road
    Blue Ash, OH USA 45242
  • Phone: 513.984.5000

Executives

Name Title Contact Details

Funding

Aprecia raised $30 M on 07/06/2016

Similar Companies

Innovage

InnovAge helps seniors age in their own homes with dignity through the Program of All-inclusive Care for the Elderly (PACE). InnovAge is dedicated to expanding this successful program to serve as many seniors as possible across the country. We hire exceptional people for our programs in California, Colorado, New Mexico, Pennsylvania, and Virginia. Our mission is to sustain and enhance the independence and quality of life for those we serve, on their terms. Our purpose is to help older adults remain mobile, prolong their health, and continue living in their own homes.

Erchonia Medical

Erchonia Medical is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Mckinney, TX. To find more information about Erchonia Medical, please visit www.erchonia.com

Innovative Neurotronics

Innovative Neurotronics, Inc. is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clinica Medical Research

Clinica Medical Research is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stilla Technologies

Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.